To cite this paper use one of the standards below:
Please log in to watch the video
Log inBackground: In 2022, lung cancer was the most frequently diagnosed type of cancer, with its high mortality primarily linked to metastasis, a process associated with the migratory and invasive capacity of tumor cells. Several studies indicate that cell migratory capacity is correlated with increased expression of metalloproteinases. Interestingly, the flavone Cirsimarin, isolated from the plant Scoparia dulcis, demonstrated anti-migratory activity in breast tumor cells (MCF-7) by downregulating the genes MMP-2 and MMP-9. If this finding is also observed in lung tumor cells, it may represent a promising strategy in the fight against lung cancer. Aim: To investigate the anti-migratory effects of Cirsimarin, as well as the modulation of metalloproteinases gene expression (MMP-2, MMP-9, and MMP-11) in A549 lung tumor cells. Methodology: The anti-migratory effects were evaluated through wound healing assay and gene expression analysis (RT-qPCR) in a 2D model, as well as an extracellular matrix 3D migration assay. Data were analyzed using two-way ANOVA with Dunnett or Tukey post-tests (p≤0.05), and gene expression differences by Student’s t-test. Results: In 2D culture, cells treated with the solvent control achieved nearly 100% wound closure within 24h. In contrast, Cirsimarin (1-40μM) demonstrated significantly impaired wound closure even after 72h of treatment, indicating an inhibition of migration at these concentrations. In 3D culture, after 48h of treatment with Cirsimarin (160μM), the cell migration area was reduced. Additionally, a disparity was observed in the structure of spheroids exposed to Cirsimarin (≥ 40 μM), which exhibited evident loose aggregation compared to the solvent control. After 12h of treatment with Cirsimarin (80μM), the genes MMP-2, MMP-9, and MMP-11 showed negative modulation. Conclusion: Cirsimarin plays a significant role in the migration of A549 cells, and potentially metastasis, by downregulating metalloproteinases. This work provides a basis for future research into other cellular pathways involved in cirsimarin's anticancer potential.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper